Nicergolin Neuraxpharm (Nicergoline)

Nicergoline, the active ingredient in Nicergolin Neuraxpharm, is an ergot alkaloid presented as an oral dosage form for oral use. It acts as a cerebral vasodilator and nootropic to support cognitive function in patients with vascular‑related cognitive decline, including vascular dementia and Alzheimer’s disease.

GNH USA supplies Nicergolin Neuraxpharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nicergoline is employed as a cerebral vasodilator and nootropic in disorders affecting cerebral blood flow and cognition.

- Cognitive decline: improves cerebral perfusion and may support memory function in patients with age‑related or vascular‑related decline. - Vascular dementia: helps alleviate symptoms by enhancing blood flow to affected brain regions. - Cerebrovascular insufficiency: increases cerebral circulation, reducing ischemic episodes. - Alzheimer’s disease: used as an adjunct to improve cognitive symptoms by promoting neuronal metabolism.

Nicergoline may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache: mild to moderate intensity. - Dizziness or vertigo. - Nausea or gastrointestinal discomfort. - Flushing or warmth sensation.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Cardiac arrhythmias: irregular heart rhythm.

When prescribing Nicergoline, clinicians should consider several precautionary measures to ensure safe use.

- Assess cardiovascular status: evaluate blood pressure and heart disease before initiation. - Monitor liver function: periodic liver enzyme testing is advised. - Use cautiously in renal impairment: adjust therapy based on renal function. - Avoid in patients with known hypersensitivity to ergot derivatives. - Review concomitant medications: consider potential interactions with antihypertensives and anticoagulants. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture.

Nicergoline can affect the pharmacodynamics of several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Combined use with potent vasodilators (e.g., nitroglycerin): may cause excessive hypotension. - Concurrent ergot alkaloids (e.g., ergotamine): risk of additive vasospasm and toxicity. - Strong CYP3A4 inhibitors (e.g., ketoconazole): increase nicergoline plasma levels.

Moderate Interactions (Monitor Closely): - Antihypertensive agents (e.g., ACE inhibitors): may enhance blood pressure‑lowering effect. - Anticoagulants/antiplatelet drugs (e.g., warfarin, aspirin): monitor for bleeding tendency. - SSRIs or SNRIs: potential additive effect on platelet function.